Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

September 2003

Orthopedic Agonistes BY EDITOR, SEPTEMBER 29, 2003

Orthopedics, the self-made industry, is troubled and struggling. At least that was the tone at last week's OrthoKnow Symposium (one of the best of such industry gatherings) as distributors and their fellow travelers gathered to discuss the state of orthopedics.... more

Osteotech lays off 5% of its workforce – adds, management estimates, a nickel a share to 2004 earnings BY EDITOR, SEPTEMBER 29, 2003

But the conference call explaining the decision isn't scheduled until October 3rd. So why announce now? Word was leaking out and instead of letting rumors erode employee morale, management decided to get in front of the news. That makes sense.... more

Venture Capital "tone" dramatically positive BY EDITOR, SEPTEMBER 29, 2003

Dave Stassen, legendary medical device venture capitalist and principal at the $3 billion St. Paul Ventures in Minnesota is calling a turn in medical device venture investment. In his talk at the OrthoKnow symposium last week, Stassen recounted the recent... more

Of Zoomers, Boomers and Macaroomers BY EDITOR, SEPTEMBER 29, 2003

The data we see coming from the Centers for Medicare and Medicaid (CMS) tells us that the large joint reconstruction market is being driven by people born before 1944. Not Boomers. Not Zoomers – whatever they are – or any... more

Spine Summit Line-Up Extraordinary BY EDITOR, SEPTEMBER 22, 2003

Presenting at our October 9th Spine Summit will be, in no particular order: The most innovative supplier of hemostatic products for the spine that no one has heard of. The best surgical assist (a semi-robot) for spine surgeons we've ever... more

Biomet's Announcement Offers 3rd Quarter Preview BY EDITOR, SEPTEMBER 22, 2003

What makes the Orthopedic Industry's current renaissance so interesting is not only how unexpected it is, but how unexpectedly broad and deep it is. Unlike the cardiovascular industry, which is riding the drug coated stent phenomenon, orthopedic revenues are bubbling... more

Does Centerpulse feel the love yet? BY EDITOR, SEPTEMBER 8, 2003

86.7% of the outstanding shares of Centerpulse held by individual shareholders or Incentive Capital have been tendered to Zimmer. Ray Elliott, CEO of Zimmer Holdings, is now an ex-officio member of the American Swiss Foundation Board of Directors. (The Foundation... more

GenSci Set to Emerge from Bankruptcy with $50 Million in Cash, over $23 Million in Sales and a New DBM Product. BY EDITOR, SEPTEMBER 8, 2003

GenSci Orthobiologics is in the final stages of emerging from Chapter 11 bankruptcy. ISOTIS, the Netherlands based tissue engineering company, is merging with GenSci and setting the stage for a dramatic and interesting rebirth of this company that many, including... more

There's more than one way to grow bone BY EDITOR, SEPTEMBER 8, 2003

In this era of recombinant bone morphogenic proteins that cost $5,000 per patient per level, it's refreshing to note that there are more ways to jump start bone healing. Last week, Orthofix announced it had submitted data to the FDA... more

Rookie bone void fill may be best yet BY EDITOR, SEPTEMBER 2, 2003

Here's a trick question for all you orthopods reading this newsletter. Name the bone void fill for spinal applications with 9 years of documented clinical success, an FDA controlled randomized clinical trial and over 75,000 cases at 1,500 hospitals. Grafton?... more

Public Orthopedic Revenues Jump 18% in First Half of 2003 – A New Record BY EDITOR, SEPTEMBER 2, 2003

We told you so. We said orthopedic industry revenues were accelerating. We just didn't predict that they'd be this strong. We were thinking 16%. Now that the last conference call of the second quarter is over, we've added up all... more


Complete Archive